GL1X · GenesisL1 explorer

Research workbench

An orally-bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide bond replacement. crystallographic and pharmacokinetic analysis

Analyse An orally-bioavailable HIV-1 protease inhibitor containing an imidazole-derived… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1SBG
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
UniProt
P03366
Ligands
IM1
Pockets
1 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 58% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 proteaseprotein994% helix, 58% strandP03366

Ligands and binding sites

  • IM1 · (2R,4S,5S,1'S)-2-phenylmethyl-4-hydroxy-5-(tert-butoxycarbonyl)amino-6-phenyl hexanoyl-N-(1'-imidazo-2-yl)-2'-methylpropanamide · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13520.710.8335IM1

Interfaces

1 interface between chains.

  • A–B · 1830 Ų buried · 35 hydrogen bonds · protein-protein

Compared structures

  • 1SBG · An orally-bioavailable HIV-1 protease inhibitor containing an imidazole-derived peptide… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.